Home ➤ Life Science ➤ Diagnostics ➤ Irritable Bowel Syndrome Treatment Market
Irritable Bowel Syndrome Treatment Market
Published date: March 2025 • Formats:
[email protected] +1 718 874 1545
Request Sample Schedule a Call

Table of Contents

Irritable Bowel Syndrome Treatment Market By Type (IBS-D, IBS-C, IBS-S, and IBS-U), By Drug Class (Linzess/Constella, Xifaxan, Viberzi, Amitiza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: March 2025
  • Report ID: 143132
  • Number of Pages: 206
  • Format:
Fact Checked
Irritable Bowel Syndrome Treatment Market https://market.us/report/global-irritable-bowel-syndrome-treatment-market/
Cite this Research
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Irritable Bowel Syndrome Treatment Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Irritable Bowel Syndrome Treatment Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Irritable Bowel Syndrome Treatment Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 3.3. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
        • 3.3.1. IBS-C
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. IBS-D
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
      • 3.4. Global Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 3.5. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
        • 3.5.1. Xifaxan
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Linzess/Constella
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Viberzi
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Amitiza
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Others
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
      • 3.6. Global Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 3.7. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
        • 3.7.1. Hospital Pharmacy
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Retail Pharmacy
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Others
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
    • 4. Global Irritable Bowel Syndrome Treatment Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Region
    • 5. North America Irritable Bowel Syndrome Treatment Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 5.3. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • 5.4. North America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 5.5. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • 5.6. North America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 5.7. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • 5.8. North America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Irritable Bowel Syndrome Treatment Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 6.3. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • 6.4. Europe Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 6.5. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • 6.6. Europe Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 6.7. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • 6.8. Europe Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Irritable Bowel Syndrome Treatment Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 7.3. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • 7.4. Asia Pacific Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 7.5. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • 7.6. Asia Pacific Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 7.7. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • 7.8. Asia Pacific Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Irritable Bowel Syndrome Treatment Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 8.3. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • 8.4. Latin America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 8.5. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • 8.6. Latin America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 8.7. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • 8.8. Latin America Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Irritable Bowel Syndrome Treatment Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 9.3. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • 9.4. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
      • 9.5. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • 9.6. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
      • 9.7. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • 9.8. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Allergan plc
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Takeda Pharmaceutical Company Limited
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Ironwood Pharmaceuticals Inc.
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Valeant Pharmaceuticals International Inc.
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Synergy Pharmaceuticals Inc.
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Salix Pharmaceuticals Inc.
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Ardelyx Inc.
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Astellas Pharma Inc.
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Lexicon Pharmaceuticals Inc.
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Norgine B.V.
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. Sebela Pharmaceuticals Inc.
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. RedHill Biopharma Ltd.
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
        • 10.7.13. Pfizer Inc.
          • 10.7.13.1. Company Details
          • 10.7.13.2. Business Overview
          • 10.7.13.3. Product Portfolio
          • 10.7.13.4. Financial Insights
          • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.13.6. SWOT Analysis
          • 10.7.13.7. Geographic Footprint
        • 10.7.14. Probi AB
          • 10.7.14.1. Company Details
          • 10.7.14.2. Business Overview
          • 10.7.14.3. Product Portfolio
          • 10.7.14.4. Financial Insights
          • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.14.6. SWOT Analysis
          • 10.7.14.7. Geographic Footprint
        • 10.7.15. Abbott Laboratories.
          • 10.7.15.1. Company Details
          • 10.7.15.2. Business Overview
          • 10.7.15.3. Product Portfolio
          • 10.7.15.4. Financial Insights
          • 10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.15.6. SWOT Analysis
          • 10.7.15.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 2. Global Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 3. Global Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 4. Global Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 6. North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 7. North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 8. North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 10. The US Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 11. The US Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 12. Canada Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 13. Canada Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 14. Canada Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 15. Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 16. Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 17. Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 18. Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 20. Germany Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 21. Germany Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 22. The UK Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 23. The UK Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 24. The UK Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 25. France Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 26. France Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 27. France Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 28. Spain Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 29. Spain Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 30. Spain Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 31. Italy Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 32. Italy Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 33. Italy Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 34. Russia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 35. Russia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 36. Russia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 37. Netherland Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 38. Netherland Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 39. Netherland Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 40. Rest of Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 41. Rest of Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 42. Rest of Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 43. Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 44. Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 45. Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 46. Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 48. China Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 49. China Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 50. India Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 51. India Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 52. India Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 53. Japan Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 54. Japan Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 55. Japan Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 56. South Korea Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 57. South Korea Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 58. South Korea Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 59. Australia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 60. Australia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 61. Australia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 62. New Zealand Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 63. New Zealand Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 64. New Zealand Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 65. Singapore Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 66. Singapore Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 67. Singapore Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 68. Thailand Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 69. Thailand Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 70. Thailand Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 71. Vietnam Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 72. Vietnam Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 73. Vietnam Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 74. Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 75. Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 76. Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 77. Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 78. Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 79. Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 80. Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 82. Brazil Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 83. Brazil Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 84. Mexico Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 85. Mexico Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 86. Mexico Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 87. Rest of Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 88. Rest of Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 89. Rest of Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 90. Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 91. Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 92. Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 93. Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 95. South Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 96. South Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 97. Saudi Arabia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 98. Saudi Arabia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 99. Saudi Arabia Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 100. UAE Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 101. UAE Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 102. UAE Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
      • Table 103. Rest of Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Type, 2020-2034
      • Table 104. Rest of Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
      • Table 105. Rest of Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
    • List of Figures
      • Figure 1. Global Irritable Bowel Syndrome Treatment Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Irritable Bowel Syndrome Treatment Market
      • Figure 5. Global Irritable Bowel Syndrome Treatment Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 6. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • Figure 7. Global Irritable Bowel Syndrome Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 8. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 9. Global Irritable Bowel Syndrome Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 10. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 11. Global Irritable Bowel Syndrome Treatment Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Region
      • Figure 13. North America Irritable Bowel Syndrome Treatment Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 14. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • Figure 15. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-C, 2020-2034
      • Figure 16. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-D, 2020-2034
      • Figure 17. North America Irritable Bowel Syndrome Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 18. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 19. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Xifaxan, 2020-2034
      • Figure 20. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Linzess/Constella, 2020-2034
      • Figure 21. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Viberzi, 2020-2034
      • Figure 22. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Amitiza, 2020-2034
      • Figure 23. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 24. North America Irritable Bowel Syndrome Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 25. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 26. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 27. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 28. North America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 29. North America Irritable Bowel Syndrome Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 30. North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
      • Figure 31. Europe Irritable Bowel Syndrome Treatment Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 32. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • Figure 33. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-C, 2020-2034
      • Figure 34. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-D, 2020-2034
      • Figure 35. Europe Irritable Bowel Syndrome Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 36. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 37. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Xifaxan, 2020-2034
      • Figure 38. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Linzess/Constella, 2020-2034
      • Figure 39. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Viberzi, 2020-2034
      • Figure 40. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Amitiza, 2020-2034
      • Figure 41. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 42. Europe Irritable Bowel Syndrome Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 43. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 44. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 45. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 46. Europe Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 47. Europe Irritable Bowel Syndrome Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 48. Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
      • Figure 49. Asia Pacific Irritable Bowel Syndrome Treatment Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 50. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • Figure 51. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-C, 2020-2034
      • Figure 52. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-D, 2020-2034
      • Figure 53. Asia Pacific Irritable Bowel Syndrome Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 54. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 55. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Xifaxan, 2020-2034
      • Figure 56. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Linzess/Constella, 2020-2034
      • Figure 57. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Viberzi, 2020-2034
      • Figure 58. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Amitiza, 2020-2034
      • Figure 59. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 60. Asia Pacific Irritable Bowel Syndrome Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 61. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 62. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 63. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 64. Asia Pacific Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 65. Asia Pacific Irritable Bowel Syndrome Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 66. Asia Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
      • Figure 67. Latin America Irritable Bowel Syndrome Treatment Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 68. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • Figure 69. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-C, 2020-2034
      • Figure 70. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-D, 2020-2034
      • Figure 71. Latin America Irritable Bowel Syndrome Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 72. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 73. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Xifaxan, 2020-2034
      • Figure 74. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Linzess/Constella, 2020-2034
      • Figure 75. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Viberzi, 2020-2034
      • Figure 76. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Amitiza, 2020-2034
      • Figure 77. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 78. Latin America Irritable Bowel Syndrome Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 79. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 80. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 81. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 82. Latin America Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 83. Latin America Irritable Bowel Syndrome Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 84. Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
      • Figure 85. Middle East & Africa Irritable Bowel Syndrome Treatment Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 86. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Type
      • Figure 87. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-C, 2020-2034
      • Figure 88. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by IBS-D, 2020-2034
      • Figure 89. Middle East & Africa Irritable Bowel Syndrome Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
      • Figure 90. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Class
      • Figure 91. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Xifaxan, 2020-2034
      • Figure 92. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Linzess/Constella, 2020-2034
      • Figure 93. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Viberzi, 2020-2034
      • Figure 94. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Amitiza, 2020-2034
      • Figure 95. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 96. Middle East & Africa Irritable Bowel Syndrome Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
      • Figure 97. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
      • Figure 98. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 99. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 100. Middle East & Africa Irritable Bowel Syndrome Treatment Market (US$ Mn), by Others, 2020-2034
      • Figure 101. Middle East & Africa Irritable Bowel Syndrome Treatment Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 102. Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
    • Allergan plc
    • Takeda Pharmaceutical Company Limited
    • Ironwood Pharmaceuticals Inc.
    • Synergy Pharmaceuticals Inc.
    • Salix Pharmaceuticals Inc.
    • Ardelyx Inc.
    • Astellas Pharma Inc.
    • Lexicon Pharmaceuticals Inc.
    • Sebela Pharmaceuticals Inc.
    • RedHill Biopharma Ltd.
    • Pfizer Inc.
    • Probi AB
Irritable Bowel Syndrome Treatment Market
Irritable Bowel Syndrome Treatment Market
Published date: March 2025
add_shopping_cartBuy Now get_appDownload Sample

Related Reports

Irritable Bowel Syndrome Treatment Market
  • 143132
  • March 2025
    • ★★★★★
      ★★★★★
Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo

Our Clients

✖
Request a Sample Report
We'll get back to you as quickly as possible

✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options